What is the recommended dosing regimen for a rocuronium infusion, including initial bolus and maintenance rates, in adults and pediatric patients?

Rocuronium Infusion Dosing

For rocuronium infusion in adults, initiate at 10-12 mcg/kg/min only after early evidence of spontaneous recovery from the intubating dose, then titrate individually to maintain 1-2 twitches in train-of-four (TOF) monitoring, with typical maintenance rates ranging from 4-16 mcg/kg/min. 1

Initial Bolus Dosing

Adults

• Standard intubation: 0.6 mg/kg provides excellent intubating conditions in approximately 2 minutes 1
• Rapid sequence intubation: 0.6 mg/kg achieves intubation conditions in 60-90 seconds (though duration is longer than succinylcholine) 1
• Higher doses: 0.9-1.2 mg/kg for faster onset when clinically indicated 1

Pediatric Patients

• Recommended initial dose: 0.6 mg/kg 1
• Alternative lower dose: 0.45 mg/kg may be used depending on anesthetic technique and age 1
• With sevoflurane induction: Both 0.45 and 0.6 mg/kg produce excellent intubating conditions within 75 seconds 1
• With halothane: 0.6 mg/kg produces excellent conditions within 60 seconds 1

Important caveat: Rocuronium is NOT recommended for rapid sequence intubation in pediatric patients or obstetric patients undergoing Cesarean section 1

Maintenance Infusion Regimen

Adults

Initiation timing is critical: Start infusion only after early evidence of spontaneous recovery (ideally at 10% T1 recovery). Starting too late (>10% T1) may require additional boluses to maintain adequate blockade 1

Initial infusion rate: 10-12 mcg/kg/min 1

Maintenance range: 4-16 mcg/kg/min, adjusted based on TOF monitoring 1

Key adjustment: With volatile anesthetics (enflurane or isoflurane), reduce infusion rate by 30-50% at 45-60 minutes after intubating dose 1

Pediatric Patients

Maintenance options:

• Bolus method: 0.15 mg/kg at reappearance of T3 (third twitch in TOF) 1
• Infusion method: 7-10 mcg/kg/min starting at reappearance of T2 1

Age-specific requirements:

• Neonates (birth to <28 days): Lowest dose requirements 1
• Children (>2 years to 11 years): Highest dose requirements 1
• Infants: Intermediate requirements 1

With halothane: Maintenance doses of 0.075-0.125 mg/kg upon return of T1 to 25%, or continuous infusion at 12 mcg/kg/min upon return of T1 to 10% 1

Practical Infusion Preparation

The FDA label provides three concentration options 1:

1. 0.5 mg/mL: 50 mg rocuronium in 100 mL solution
2. 1 mg/mL: 100 mg rocuronium in 100 mL solution
3. 5 mg/mL: 500 mg rocuronium in 100 mL solution

Compatible diluents: 5% glucose in water or lactated Ringer's 1

Stability: Use infusion solutions within 24 hours of mixing; discard unused portions 1

Special Population Considerations

Geriatric Patients (≥65 years)

• Use standard initial doses (0.6 mg/kg) 1
• Expect slightly prolonged clinical duration: median 46-94 minutes depending on dose 1
• Recovery times are NOT significantly prolonged compared to younger adults 1

Obese Patients

• Dose based on actual body weight (ABW), not ideal body weight 1
• Dosing by ideal body weight results in longer onset, shorter duration, and inadequate intubating conditions 1

Renal/Hepatic Failure

• Consider benzylisoquinoline muscle relaxants (atracurium/cisatracurium) as preferred alternatives 2
• If rocuronium is used, expect increased duration and greater interindividual variability 2

Critical Monitoring Requirements

Neuromuscular monitoring is mandatory for safe rocuronium infusion 2, 3:

• Monitor TOF at the adductor pollicis (hand) 2
• Target maintenance: 1-2 twitches in TOF for surgical relaxation 1
• Before extubation: Confirm TOF ratio ≥0.9 quantitatively 3

Why hand monitoring matters: Recovery at hand muscles indicates recovery of upper airway muscles, which are more sensitive to rocuronium 3

Recovery and Reversal Considerations

Spontaneous recovery: After stopping infusion, recovery proceeds at rates comparable to equivalent total bolus doses 1

Reversal with sugammadex (dose depends on depth of block) 2:

• Very moderate block (TOF ratio 0.5): 0.22 mg/kg
• Moderate block (4 TOF responses): 1.0 mg/kg
• Moderate block (2 TOF responses): 2.0 mg/kg
• Deep block (PTC 1-2): 4.0 mg/kg
• Very deep block/immediate reversal: 8.0 mg/kg

Critical warning: Inadequate sugammadex dosing causes recurarization 2. Continue monitoring after reversal to detect this complication.

Bolus vs. Infusion: Evidence Comparison

Recent research shows equivalent total rocuronium requirements between intermittent bolus and continuous infusion strategies when normalized for time and body weight 4. However:

• Continuous infusion may require 18-20% rescue boluses in some patients 4
• In pediatric patients, continuous infusion uses significantly less rocuronium than intermittent bolus (4.9 vs. 6.1 mcg/kg/min) with similar recovery times 5
• Recovery times do not differ significantly between methods 4, 5

Clinical implication: Either method is acceptable, but continuous infusion requires vigilant TOF monitoring and readiness to administer rescue boluses.